(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9.22%3.17B | -16.56%1.56B | 85.91%2.91B | 98.32%1.87B | 82.05%1.56B | 249.99%941M | -23.70%858.42M | -66.40%268.87M | 44.84%1.12B | 122.03%800.15M |
Operating income | 9.22%3.17B | -16.56%1.56B | 85.91%2.91B | 98.32%1.87B | 82.05%1.56B | 249.99%941M | -23.70%858.42M | -66.40%268.87M | 44.84%1.12B | 122.03%800.15M |
Cost of sales | -9.13%-1.99B | 8.89%-978.53M | -92.01%-1.82B | -110.16%-1.07B | -72.49%-947.97M | -201.71%-511.02M | 14.89%-549.58M | 61.05%-169.37M | -46.46%-645.76M | -109.57%-434.83M |
Operating expenses | -9.13%-1.99B | 8.89%-978.53M | -92.01%-1.82B | -110.16%-1.07B | -72.49%-947.97M | -201.71%-511.02M | 14.89%-549.58M | 61.05%-169.37M | -46.46%-645.76M | -109.57%-434.83M |
Gross profit | 9.38%1.19B | -26.95%578.73M | 76.51%1.09B | 84.26%792.28M | 99.05%614.75M | 332.16%429.98M | -35.56%308.84M | -72.76%99.5M | 42.72%479.24M | 138.94%365.31M |
Administrative expenses | -38.72%-329.94M | -87.91%-166.87M | -45.76%-237.85M | -25.27%-88.8M | -3.61%-163.18M | 3.06%-70.89M | 6.91%-157.49M | 1.89%-73.12M | -27.67%-169.18M | -15.81%-74.53M |
Revaluation surplus | 416.27%959.33M | 177.94%326.27M | -263.95%-303.32M | -98.58%-418.62M | -80.64%185.02M | 70.50%-210.81M | -18.69%955.69M | -882,404.94%-714.67M | 1,749.66%1.18B | -99.87%81K |
-Changes in the fair value of derivative financial instruments | 416.27%959.33M | 177.94%326.27M | -263.95%-303.32M | -98.58%-418.62M | -80.64%185.02M | 70.50%-210.81M | -18.69%955.69M | -882,404.94%-714.67M | 1,749.66%1.18B | -99.87%81K |
Impairment and provision | 179.64%1.08B | -20.76%-663.14M | -225.81%-1.36B | -348.84%-549.14M | -137.29%-418.08M | 340.89%220.68M | 88.87%1.12B | 70.18%-91.61M | 38.60%593.67M | -12,150.28%-307.24M |
-Impairment of intangible assets | 197.58%125.12M | -2.53%-55.78M | -227.04%-128.23M | -308.08%-54.41M | -129.66%-39.21M | 386.02%26.15M | 90.73%132.19M | 68.94%-9.14M | 37.34%69.3M | ---29.43M |
-Impairment of property, machinery and equipment | 178.37%965.06M | -22.47%-604.64M | -226.50%-1.23B | -353.38%-493.69M | -138.19%-377.17M | 336.22%194.84M | 89.06%987.71M | 70.27%-82.49M | 37.92%522.44M | ---277.47M |
-Other impairment is provision | -119.74%-5.4M | -161.85%-2.72M | -44.44%-2.46M | -230.57%-1.04M | -226.09%-1.7M | -2,062.50%-314K | -29.96%1.35M | 104.78%16K | 309.12%1.93M | 86.64%-335K |
Special items of operating profit | -164.97%-31.16M | 2.97%-6.7M | 169.55%47.96M | -1.63%-6.9M | -78.72%17.79M | -123.11%-6.79M | -65.56%83.61M | 1,278.05%29.38M | 1,123.53%242.8M | 106.05%2.13M |
Operating profit | 472.59%2.87B | 125.18%68.29M | -425.97%-770.25M | -174.88%-271.19M | -89.78%236.3M | 148.26%362.18M | -0.43%2.31B | -5,169.05%-750.52M | 245.80%2.32B | -112.46%-14.24M |
Financing cost | -9.46%-655.86M | -15.56%-339.16M | -10.28%-599.21M | -10.51%-293.49M | -10.61%-543.37M | -5.15%-265.57M | 38.65%-491.23M | 38.40%-252.57M | -8.90%-800.68M | -15.81%-409.99M |
Earning before tax | 261.67%2.21B | 52.03%-270.87M | -345.98%-1.37B | -684.51%-564.68M | -116.87%-307.07M | 109.63%96.61M | 19.69%1.82B | -136.45%-1B | 2,483.33%1.52B | -77.01%-424.24M |
Tax | -129.46%-536.12M | -52.24%-275.97M | -456.52%-233.64M | -275.42%-181.27M | -64.15%-41.98M | -948.99%-48.29M | 67.72%-25.58M | 92.67%-4.6M | -508.37%-79.22M | -1,884.91%-62.83M |
After-tax profit from continuing operations | 204.67%1.68B | 26.69%-546.84M | -359.27%-1.6B | -1,643.70%-745.95M | -119.44%-349.05M | 104.80%48.32M | 24.49%1.8B | -106.89%-1.01B | 3,345.78%1.44B | -106.26%-487.07M |
Earning after tax | 204.67%1.68B | 26.69%-546.84M | -359.27%-1.6B | -1,643.70%-745.95M | -119.44%-349.05M | 104.80%48.32M | 24.49%1.8B | -106.89%-1.01B | 3,345.78%1.44B | -106.26%-487.07M |
Profit attributable to shareholders | 204.67%1.68B | 26.69%-546.84M | -359.27%-1.6B | -1,643.70%-745.95M | -119.44%-349.05M | 104.80%48.32M | 24.49%1.8B | -106.89%-1.01B | 3,345.78%1.44B | -106.26%-487.07M |
Basic earnings per share | 204.69%8.92 | 26.70%-2.91 | -358.06%-8.52 | -1,626.92%-3.97 | -119.50%-1.86 | 104.85%0.26 | 24.54%9.54 | -106.95%-5.36 | 3,291.67%7.66 | -1,963.75%-2.59 |
Diluted earnings per share | 204.69%8.92 | 26.70%-2.91 | -358.06%-8.52 | -3,153.85%-3.97 | -602.70%-1.86 | 102.43%0.13 | 146.67%0.37 | -106.95%-5.36 | 162.50%0.15 | -1,963.75%-2.59 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | -- | Ernst & Young Limited | -- | Ernst & Young Limited | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data